MedTrace Logo

Quality of Life in Patients With Multiple Myeloma-validation Study

NCT03537222 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2021-10-14

No results posted yet for this study

Summary

In this study, the Myeloma Patient Outcome Scale (MyPOS) will be translated from English to German. This translated version will be quantitatively and qualitatively validated with patients with multiple myeloma.

Conditions

Interventions

DIAGNOSTIC_TEST

Myeloma Patient Outcome Scale (MyPOS)

Patients complete the MyPOS questionnaire on quality of life

Sponsors & Collaborators

  • Kantonsspital Münsterlingen

    collaborator OTHER

  • Kantonsspital Aarau

    collaborator OTHER

  • Klinik Hirslanden, Zurich

    collaborator OTHER

  • Celgene Corporation

    collaborator INDUSTRY

  • King's College London

    collaborator OTHER

  • Zurich University of Applied Sciences

    lead OTHER

Principal Investigators

  • Julia Dratva, Prof.Dr.med · Zurich University of Applied Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03537222 on ClinicalTrials.gov